An uncommon case of Chromobacterium violaceum urinary tract infection in a tertiary hospital in Ghana: a case report
Abstract
Introduction: Chromobacterium violaceum is a facultative, Gram-negative, motile bacillus that rarely causes human infections, but could lead to severe disease with high mortality when systemic spread occurs. Reported infections include bacteremia, septicemia, wound infections, skin lesions, respiratory tract infections, and rarely urinary tract infections.
Case presentation: We report a rare case of C. violaceum isolated from the urine of a 35-year-old female from the Dagomba ethnic group in the Northern Region of Ghana who presented with a recurrent right flank pain and right upper quadrant abdominal pain at the Tamale Teaching Hospital. The organism was identified through biochemical testing and whole genome sequencing. The infection resolved after two doses of azithromycin (500 mg) and five doses of metronidazole (400 mg).
Conclusion: Human infection with Chromobacterium violaceum is extremely rare in Ghana. This case represents the first documented C. violaceum-associated urinary tract infection in the country and provides detailed perspectives into its biochemistry, antimicrobial susceptibility, and genomic characteristics. Greater clinical and laboratory awareness of this pathogen is essential for timely diagnosis and management of similar rare infections.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.